David A. Tuveson
Impact in
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 131
- Pancreatic and Hepatic Oncology Research 84
- Cancer Cells and Metastasis 53
- Cancer-related Molecular Pathways 13
-
- Cancer Genomics and Diagnostics 35
- Cancer, Hypoxia, and Metabolism 13
- Co-authors
- Tyler JacksIok In Christine ChioSunil R. HingoraniRalph H. HrubanClaudia TonelliRoderick T. BronsonDenise CrowleyAlbrecht Neeße
- Journals
- Cancer Research (24 papers)Journal of Clinical Oncology (12 papers)Cancer Cell (12 papers)Gut (10 papers)Clinical Cancer Research (8 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David A. Tuveson
195 papers receiving 40.4k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Oncology 21.2k
- Cancer Research 9.4k
- Gastroenterology 2.1k
- Immunology 7.5k
- Molecular Biology 19.6k
Countries citing papers authored by David A. Tuveson
This map shows the geographic impact of David A. Tuveson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Tuveson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Tuveson more than expected).
Fields of papers citing papers by David A. Tuveson
This network shows the impact of papers produced by David A. Tuveson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Tuveson. The network helps show where David A. Tuveson may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Tuveson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 14 | |
| 4 | Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction Hit paper breakdown → | 2024 | 104 |
| 5 | Activated fibroblasts in cancer: Perspectives and challenges Hit paper breakdown → | 2023 | 210 |
| 6 | 2021 | 89 | |
| 7 | 2020 | 128 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 139 | |
| 10 | 2019 | 58 | |
| 11 | 2019 | 41 | |
| 12 | IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2018 | 891 |
| 13 | 2017 | 72 | |
| 14 | 2016 | 193 | |
| 15 | 2012 | 320 | |
| 16 | 2011 | 107 | |
| 17 | Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α Hit paper breakdown → | 2010 | 918 |
| 18 | 2007 | 129 | |
| 19 | Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion Hit paper breakdown → | 2007 | 745 |
| 20 | 2006 | 17 |
About David A. Tuveson
David A. Tuveson is a scholar working on Oncology, Cancer Research, Biotechnology, Molecular Biology and Immunology, having authored 200 papers that have together received 41.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (84 papers), Cancer Cells and Metastasis (53 papers), Cancer Genomics and Diagnostics (35 papers), Epigenetics and DNA Methylation (17 papers), Cancer Research and Treatments (15 papers), Pancreatic function and diabetes (13 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Cancer-related Molecular Pathways (13 papers). The work is most often cited by research in Oncology (21.2k citations), Cancer Research (9.4k citations), Gastroenterology (2.1k citations), Immunology (7.5k citations) and Molecular Biology (19.6k citations). David A. Tuveson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Tyler Jacks, Iok In Christine Chio, Sunil R. Hingorani, Ralph H. Hruban, Claudia Tonelli, Roderick T. Bronson, Denise Crowley, Albrecht Neeße, Giulia Biffi and Hans Clevers. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Cell, Gut and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.